Consolidated Statements of Changes in Contingently Redeemable Convertible Preferred Stock and Stockholders’ Equity - USD ($) $ in Thousands	Total	Previously Reported	Retroactive application of the recapitalization	Contingently Redeemable Convertible Preferred Stock	Contingently Redeemable Convertible Preferred Stock Previously Reported	Contingently Redeemable Convertible Preferred Stock Retroactive application of the recapitalization	Common Stock	Common Stock Previously Reported	Common Stock Retroactive application of the recapitalization	Additional Paid-in Capital	Additional Paid-in Capital Previously Reported	Accumulated Deficit	Accumulated Deficit Previously Reported	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2020				10,826,000	6,766,000	4,060,000
Beginning balance at Dec. 31, 2020				$ 44,476	$ 44,476
Ending balances (in shares) at Mar. 31, 2021				10,826,000
Ending balance at Mar. 31, 2021				$ 44,476
Beginning balance (in shares) at Dec. 31, 2020							157,786,000	98,607,000	59,179,000
Beginning balance at Dec. 31, 2020	$ 89,239	$ 89,224	$ 15				$ 16	$ 1	$ 15	$ 163,967	$ 163,967	$ (74,744)	$ (74,744)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	6,849											6,849
Other comprehensive income	0
Stock-based compensation	588									588
Issuances of common stock- warrants and options	496									496
Ending balance (in shares) at Mar. 31, 2021							157,786,000
Ending balance at Mar. 31, 2021	$ 97,172						$ 16			165,051		(67,895)
Beginning balance (in shares) at Dec. 31, 2020				10,826,000	6,766,000	4,060,000
Beginning balance at Dec. 31, 2020				$ 44,476	$ 44,476
Ending balances (in shares) at Dec. 31, 2021	10,826,000			10,826,000
Ending balance at Dec. 31, 2021	$ 44,476			$ 44,476
Beginning balance (in shares) at Dec. 31, 2020							157,786,000	98,607,000	59,179,000
Beginning balance at Dec. 31, 2020	89,239	$ 89,224	$ 15				$ 16	$ 1	$ 15	163,967	$ 163,967	(74,744)	$ (74,744)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Costs attributable to issuance of common stock and equity instruments- Merger with XPDI	(16,600)
Ending balance (in shares) at Dec. 31, 2021							271,576,000
Ending balance at Dec. 31, 2021	$ 1,341,210						$ 27			1,379,581		(27,432)		$ (10,966)
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of common stock - conversion of contingently redeemable preferred stock to common stock (in shares)				(10,826,000)
Issuance of common stock - conversion of contingently redeemable preferred stock to common stock				$ (44,476)
Ending balances (in shares) at Mar. 31, 2022	0			0
Ending balance at Mar. 31, 2022	$ 0			$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(466,204)											(466,204)
Other comprehensive income	27,164													27,164
Stock-based compensation	20,573									20,573
Issuance of common stock - restricted stock and restricted stock units (in shares)							6,803,000
Issuance of common stock - restricted stock and restricted stock units							$ 1			(1)
Issuance of common stock - exercise of warrants (in shares)							3,001,000
Issuance of common stock - exercise of warrants	0						$ 0
Issuance of common stock - conversion of contingently redeemable preferred stock to common stock (in shares)							10,826,000
Issuance of common stock - conversion of contingently redeemable preferred stock to common stock	44,476						$ 1			44,475
Issuances of common stock- Merger with XPDI (in shares)							30,778,000
Issuances of common stock- Merger with XPDI	163,459						$ 3			163,456
Costs attributable to issuance of common stock and equity instruments- Merger with XPDI	(16,642)									(16,642)
Issuances of common stock- vendor settlement (in shares)							1,580,000
Issuances of common stock- vendor settlement	12,674									12,674
Ending balance (in shares) at Mar. 31, 2022							324,564,000
Ending balance at Mar. 31, 2022	$ 1,126,710						$ 32			$ 1,604,116		$ (493,636)		$ 16,198